このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
Integra LifeSciences Holdings マネジメント
マネジメント 基準チェック /44
Integra LifeSciences Holdings'の CEO はJan De Witteで、 Dec2021年に任命され、 の在任期間は 2.5年です。 の年間総報酬は$ 6.39Mで、 13.7%給与と86.3%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の0.023%を直接所有しており、その価値は$ 530.39K 。経営陣と取締役会の平均在任期間はそれぞれ3.2年と11.1年です。
主要情報
Jan De Witte
最高経営責任者
US$6.4m
報酬総額
| CEO給与比率 | 13.7% |
| CEO在任期間 | 2.5yrs |
| CEOの所有権 | 0.02% |
| 経営陣の平均在職期間 | 3.2yrs |
| 取締役会の平均在任期間 | 11.1yrs |
経営陣の近況
Recent updates
Integra LifeSciences Still Underperforming As Manufacturing Issues Linger
Jun 21Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Intrinsic Value Is Potentially 40% Above Its Share Price
May 28
Returns On Capital At Integra LifeSciences Holdings (NASDAQ:IART) Have Stalled
Feb 27We Think Integra LifeSciences Holdings (NASDAQ:IART) Can Stay On Top Of Its Debt
Feb 11Is Now An Opportune Moment To Examine Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Jan 14Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Price In Tune With Earnings
Dec 31Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Trading At A 46% Discount?
Dec 03Does Integra LifeSciences Holdings (NASDAQ:IART) Have A Healthy Balance Sheet?
Nov 06Integra LifeSciences Holdings (NASDAQ:IART) Hasn't Managed To Accelerate Its Returns
Oct 24Is Now An Opportune Moment To Examine Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Sep 22Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Trading At A 38% Discount?
Aug 15Returns On Capital At Integra LifeSciences Holdings (NASDAQ:IART) Have Hit The Brakes
Jul 03Is There Now An Opportunity In Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Jun 19Estimating The Fair Value Of Integra LifeSciences Holdings Corporation (NASDAQ:IART)
May 05These 4 Measures Indicate That Integra LifeSciences Holdings (NASDAQ:IART) Is Using Debt Reasonably Well
Apr 07Integra LifeSciences Holdings (NASDAQ:IART) Is Experiencing Growth In Returns On Capital
Mar 26At US$52.61, Is It Time To Put Integra LifeSciences Holdings Corporation (NASDAQ:IART) On Your Watch List?
Mar 14Does Integra LifeSciences Holdings (NASDAQ:IART) Deserve A Spot On Your Watchlist?
Feb 27Calculating The Fair Value Of Integra LifeSciences Holdings Corporation (NASDAQ:IART)
Feb 02We Think Integra LifeSciences Holdings (NASDAQ:IART) Can Stay On Top Of Its Debt
Jan 05Here's What To Make Of Integra LifeSciences Holdings' (NASDAQ:IART) Decelerating Rates Of Return
Dec 21When Should You Buy Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Dec 08Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Trading At A 42% Discount?
Oct 19We Think Integra LifeSciences Holdings (NASDAQ:IART) Can Stay On Top Of Its Debt
Oct 05Integra LifeSciences: Wide Dislocation In Fundamentals Vs. Market Value
Sep 13Is It Time To Consider Buying Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Sep 06FDA labels recall of intracranial pressure monitors by Integra as most serious
Aug 31Integra Lifesciences voluntarily recalls pressure monitors, lowers revenue, profit guidance
Aug 24Returns At Integra LifeSciences Holdings (NASDAQ:IART) Appear To Be Weighed Down
Aug 23Integra LifeSciences founder/former CEO dies
Aug 16CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | US$40m |
| Dec 31 2023 | US$6m | US$875k | US$68m |
| Sep 30 2023 | n/a | n/a | US$101m |
| Jun 30 2023 | n/a | n/a | US$131m |
| Mar 31 2023 | n/a | n/a | US$172m |
| Dec 31 2022 | US$9m | US$850k | US$181m |
| Sep 30 2022 | n/a | n/a | US$173m |
| Jun 30 2022 | n/a | n/a | US$166m |
| Mar 31 2022 | n/a | n/a | US$157m |
| Dec 31 2021 | US$899k | US$59k | US$169m |
報酬と市場: Janの 総報酬 ($USD 6.39M ) は、 US市場 ($USD 5.67M ) の同様の規模の企業の平均とほぼ同じです。
報酬と収益: Janの報酬は、過去 1 年間の会社の業績と一致しています。
CEO（最高経営責任者
Jan De Witte (60 yo)
2.5yrs
在職期間
US$6,388,756
報酬
Mr. Jan De Witte has been President, Chief Executive Officer & Director of Integra LifeSciences Holdings Corporation since December 1, 2021. He had been the Chief Executive Officer at Barco NV since Septem...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Executive Chairman | 26.5yrs | US$422.52k | 2.23% $ 52.3m | |
| President | 2.5yrs | US$6.39m | 0.023% $ 547.5k | |
| Executive VP & CFO | less than a year | US$1.67m | 0.056% $ 1.3m | |
| Senior VP of Finance & Principal Accounting Officer | 6.7yrs | US$1.25m | 0.034% $ 803.2k | |
| Executive VP | 5.6yrs | US$1.62m | 0.081% $ 1.9m | |
| Executive VP & President of Tissue Technologies | 11.5yrs | US$1.42m | 0.083% $ 1.9m | |
| Executive VP & President of Codman Specialty Surgical | 4.1yrs | US$2.83m | 0.073% $ 1.7m | |
| Corporate VP of Global Operations & Supply Chain | 3.8yrs | データなし | データなし | |
| Vice President of Global Corporate Communications & Public Relations | no data | データなし | データなし | |
| Vice President of Global Marketing | no data | データなし | データなし | |
| Executive VP & Chief Human Resources Officer | 1.4yrs | データなし | 0.033% $ 769.3k | |
| Corporate VP & Chief Digital Officer | 2.4yrs | データなし | データなし |
3.2yrs
平均在職期間
57yo
平均年齢
経験豊富な経営陣: IARTの経営陣は 経験豊富 であると考えられます ( 3.2年の平均在職年数)。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Executive Chairman | 26.5yrs | US$422.52k | 2.23% $ 52.3m | |
| President | 2.5yrs | US$6.39m | 0.023% $ 547.5k | |
| Independent Director | 15.2yrs | US$297.54k | 0.11% $ 2.5m | |
| Independent Director | 18.4yrs | US$293.28k | 0.081% $ 1.9m | |
| Independent Presiding Director | 11.1yrs | US$342.54k | 0.17% $ 4.1m | |
| Independent Director | 32.4yrs | US$306.31k | 0.089% $ 2.1m | |
| Independent Director | less than a year | US$90.68k | 0.016% $ 372.8k | |
| Independent Director | 3.2yrs | US$260.04k | 0.028% $ 653.9k | |
| Independent Director | 1.9yrs | US$297.54k | 0.021% $ 481.9k |
11.1yrs
平均在職期間
63yo
平均年齢
経験豊富なボード: IARTの 取締役会 は経験豊富で 経験豊富 です ( 11.1年の平均在任期間)。